Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-Like kinase 7

Molecular Biology of the Cell

Volumn 19, Issue 11, 2008, Pages 4968-4979

  Xu, Guoxiong ^a   Bernaudo, Stefanie ^a   Fu, Guodong ^a   Lee, Daniel Y ^b   Yang, Burton B ^b   Peng, Chun ^a  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 7; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN G2; CYCLINE; LACTACYSTIN; PROTEASOME; PROTEIN NODAL; PROTEIN SERINE THREONINE KINASE; S PHASE KINASE ASSOCIATED PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 1; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1C PROTEIN, HUMAN; CCNG2 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; CANCER CELL; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MECHANISM; GENE CONTROL; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; CHEMISTRY; DOWN REGULATION; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; PROTEIN BINDING; PROTEIN PROCESSING; THERMODYNAMICS; TUMOR CELL LINE; UPREGULATION;

ACTIVIN RECEPTORS, TYPE I; AMINO ACID MOTIFS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NODAL PROTEIN; OVARIAN NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; S-PHASE KINASE-ASSOCIATED PROTEINS; THERMODYNAMICS; UBIQUITIN; UP-REGULATION;

EID: 58149286563     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-03-0259     Document Type: Article

References (61)

1. Akashiba, H., Matsuki, N., and Nishiyama, N. (2006). Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons. J. Neurochem. 99, 733-744.
2. Arachchige Don, A. S., Dallapiazza, R. F., Bennin, D. A., Brake, T., Cowan,C. E., and Horne, M. C. (2006). Cyclin G2 is a centrosome-associated nucleo-cytoplasmic shuttling protein that influences microtubule stability and in duces a p53-dependent cell cycle arrest. Exp. Cell Res. 312, 4181-4204.
3. Bates, S., Rowan, S., and Vousden, K. H. (1996). Characterisation of human cyclin G1 and G2, DNA damage inducible genes. Oncogene 13, 1103-1109.
4. Bennin, D. A., Don, A. S., Brake, T., McKenzie, J. L., Rosenbaum, H., Ortiz, L., DePaoli-Roach, A. A., and Horne, M. C. (2002). Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J. Biol. Chem. 277, 27449-27467.
5. Bierie, B., and Moses, H. L. (2006). TGF-beta and cancer. Cytokine Growth Factor Rev. 17, 29-40.
6. Bloom, J., and Pagano, M. (2003). Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41-47.
7. Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., and Hershko, A. (2003). Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278, 25752-25757.
8. Brennan, J., Norris, D. P., and Robertson, E. J. (2002). Nodal activity in the node governs left-right asymmetry. Genes Dev. 16, 2339-2344.
9. Carrano, A. C., Eytan, E., Hershko, A., and Pagano, M. (1999). SKP2 is
10. required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193-199.
11. Chang, H., Brown, C. W., and Matzuk, M. M. (2002). Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23, 787-823.
12. Ciechanover, A. (1994). The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21.
13. Eimon, P. M., and Harland, R. M. (2002). Effects of heterodimerization and proteolytic processing on Derriere and Nodal activity: implications for mesoderm induction in Xenopus. Development 129, 3089-3103.
14. Fuchs, S. Y. (2002). The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biol. Ther. 1, 337-341.
15. Fung, T. K., Siu, W. Y., Yam, C. H., Lau, A., and Poon, R. Y. (2002). Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins. J. Biol. Chem. 277, 35140-35149.
16. Graham, H., and Peng, C. (2006). Activin receptor-like kinases: structure, function and clinical implications. Endocr. Metab. Immune Disord. Drug Targets 6, 45-58.
17. Harper, J. W. (2002). A phosphorylation-driven ubiquitination switch for cell-cycle control. Trends Cell Biol. 12, 104-107.
18. He, X., Pool, M., Darcy, K. M., Lim, S. B., Auersperg, N., Coon, J. S., and Beck, W. T. (2007). Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene 26, 4961-4968.
19. Hiramatsu, Y. et al. (2006). Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res. 66, 8477-8483.
20. Horne, M. C., Donaldson, K. L., Goolsby, G. L., Tran, D., Mulheisen, M., Hell, J. W., and Wahl, A. F. (1997). Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J. Biol. Chem. 272, 12650-12661.
21. Horne, M. C., Goolsby, G. L., Donaldson, K. L., Tran, D., Neubauer, M., and Wahl, A. F. (1996). Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J. Biol. Chem. 271, 6050-6061.
22. Ito, Y. et al. (2003). Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid. Antican-cer Res. 23, 2335-2338.
23. Jackson, P. K., and Eldridge, A. G. (2002). The SCF ubiquitin ligase: an
24. extended look. Mol. Cell 9, 923-925.
25. Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Hatakeyama, S., Nakayama, K., and Nakayama, K. I. (2003). Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl. Acad. Sci. USA 100, 10231-10236.
26. Kamura, T., Hara, T., Matsumoto, M., Ishida, N., Okumura, F., Hatakeyama, S., Yoshida, M., Nakayama, K., and Nakayama, K. I. (2004). Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat. Cell Biol. 6, 1229-1235.
27. Kiernan, R. E., Emiliani, S., Nakayama, K., Castro, A., Labbe, J. C., Lorca, T., Nakayama Ki, K., and Benkirane, M. (2001). Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the protea-some. Mol. Cell. Biol. 21, 7956-7970.
28. Kim, Y., Shintani, S., Kohno, Y., Zhang, R., and Wong, D. T. (2004). Cyclin G2 dysregulation in human oral cancer. Cancer Res. 64, 8980-8986.
29. Le, X. F., Arachchige-Don, A. S., Mao, W., Horne, M. C., and Bast, R. C., Jr. (2007). Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells. Mol. Cancer Ther. 6, 2843-2857.
30. Lee, D. Y., Deng, Z., Wang, C. H., and Yang, B. B. (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. USA 104, 20350-20355.
31. Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., and Benchimol, S. (2003). Pirh2, a p53-induced ubiq-uitin-protein ligase, promotes p53 degradation. Cell 112, 779-791.
32. Liang, M., Liang, Y. Y., Wrighton, K., Ungermannova, D., Wang, X. P., Brunicardi, F. C., Liu, X., Feng, X. H., and Lin, X. (2004). Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol. Cell. Biol. 24, 7524-7537.
33. Liu, J., Cui, Z. S., Luo, Y., Jiang, L., Man, X. H., and Zhang, X. (2004). Effect of cyclin G2 on proliferative ability of SGC-7901 cell. World J. Gastroenterol. 10, 57-1360.
34. Liu, W., Wu, G., Li, W., Lobur, D., and Wan, Y. (2007). Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol. Cell. Biol. 27, 2967-2979.
35. Maines-Bandiera, S. L., Kruk, P. A., and Auersperg, N. (1992). Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am. J.Obstet. Gynecol. 167, 729-735.
36. Martinez-Gac, L., Marques, M., Garcia, Z., Campanero, M. R., and Carrera, A. C. (2004). Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol. Cell. Biol. 24, 2181-2189.
37. Massague, J., and Chen, Y. G. (2000). Controlling TGF-beta signaling. Genes Dev. 14, 627-644.
38. Morgan, D. O. (1997). Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291.
39. Munir, S., Xu, G., Wu, Y., Yang, B., Lala, P. K., and Peng, C. (2004). Nodal and ALK7 inhibit proliferation and induce apoptosis in human trophoblast cells. J. Biol. Chem. 279, 31277-31286.
40. Nakayama, K. et al. (2000). Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19, 2069-2081.
41. Nakayama, K. I., and Nakayama, K. (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369-381.
42. Nonaka, S., Shiratori, H., Saijoh, Y., and Hamada, H. (2002). Determination of left-right patterning of the mouse embryo by artificial nodal flow. Nature 418, 96-99.
43. Patel, Y. M., and Lane, M. D. (2000). Mitotic clonal expansion during preadi-pocyte differentiation: calpain-mediated turnover of p27. J. Biol. Chem. 275, 17653-17660.
44. Pines, J. (1995). Cyclins and cyclin-dependent kinases: theme and variations. Adv. Cancer Res. 66, 181-212.
45. Pines, J., and Lindon, C. (2005). Proteolysis: anytime, any place, anywhere? Nat. Cell Biol. 7, 731-735.
46. Rechsteiner, M., and Rogers, S. W. (1996). PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21, 267-271.
47. Reissmann, E., Jornvall, H., Blokzijl, A., Andersson, O., Chang, C., Minchiotti, G., Persico, M. G., Ibanez, C. F., and Brivanlou, A. H. (2001). The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev. 15, 2010-2022.
48. Roberts, H. J., Hu, S., Qiu, Q., Leung, P. C., Caniggia, I., Gruslin, A., Tsang, B., and Peng, C. (2003). Identification of novel isoforms of activin receptor-like kinase 7 (ALK7) generated by alternative splicing and expression of ALK7 and its ligand, Nodal, in human placenta. Biol. Reprod. 68, 1719-1726.
49. Rogers, S., Wells, R., and Rechsteiner, M. (1986). Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364-368.
50. 2+channel activity. Eur J. Neurosci. 23, 2311-2320.
51. Shumway, S. D., Maki, M., and Miyamoto, S. (1999). The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J. Biol. Chem. 274, 30874-30881.
52. Sutterluty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Muller, U., and Krek, W. (1999). p45SKP2 promotes p27Kip1 degradation and induces Sphase in quiescent cells. Nat. Cell Biol. 1, 207-214.
53. Tedesco, D., Lukas, J., and Reed, S. I. (2002). The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiq-uitin ligase SCF(Skp2). Genes Dev. 16, 2946-2957.
54. Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H., and Zhang, H. (1999). p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661-664.
55. Wakefield, L. M., and Roberts, A. B. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
56. Wang, W., Ungermannova, D., Jin, J., Harper, J. W., and Liu, X. (2004). Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. On-cogene 23, 1064-1075.
57. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994). Mechanism of activation of the TGF-beta receptor. Nature 370, 341-347.
58. Xu, G., Zhong, Y., Munir, S., Yang, B. B., Tsang, B. K., and Peng, C. (2004).Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. J. Clin. Endocrinol. Metab.5523-5534.
59. Xu, G., Zhou, H., Wang, Q., Auersperg, N., and Peng, C. (2006). Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines. Mol. Cancer Res. 4, 235-246.
60. Zhang, H., Kobayashi, R., Galaktionov, K., and Beach, D. (1995). p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82, 915-925.
61. Zimmerman, C. M., and Padgett, R. W. (2000). Transforming growth factor beta signaling mediators and modulators. Gene 249, 17-30.